Data as of Sep 30, 2026, 6:36 AM
Trades Apr 17, 2023 – May 29, 2026
Issuer
2 politicians disclosed trades in ARQT (Arcutis Biotherapeutics, Inc.) between Apr 17, 2023 – May 29, 2026.
Trades
5
Politicians
2
Buy vol.
$24.0k
Sell vol.
$16.0k
Sector
A sale may close the position; filings are not a live holdings snapshot.
| Name | Last trade | Buys | Sells | Est. volume |
|---|---|---|---|---|
| Gilbert Cisneros | May 29, 2026 | 2 | 1 | $24.0k |
| Josh Gottheimer | Sep 15, 2023 | 1 | 1 | $16.0k |
| Name | Last trade | Buys | Sells | Est. volume |
|---|---|---|---|---|
| Gilbert Cisneros | May 29, 2026 | 2 | 1 | $24.0k |
| Josh Gottheimer | Sep 15, 2023 | 1 | 1 | $16.0k |
| Politician | Traded issuer | Sector | Type | Size | Traded | Trade price | Yesterday | Published | Filed after |
|---|---|---|---|---|---|---|---|---|---|
| Gilbert Cisneros | Arcutis Biotherapeutics, Inc.ARQT | Healthcare | Purchase | $1k–$15k | May 29, 2026 | $21.46 | $26.75 | Jun 8, 2026 | 10 days |
| Gilbert Cisneros | Arcutis Biotherapeutics, Inc.ARQT | Healthcare | Purchase | $1k–$15k | Mar 3, 2026 | $23.60 | $26.75 | Apr 7, 2026 | 35 days |
| Gilbert Cisneros | Arcutis Biotherapeutics, Inc.ARQT | Healthcare | Sale | $1k–$15k | Dec 11, 2025 | $29.47 | $26.75 | Jan 12, 2026 | 32 days |
| Josh Gottheimer | Arcutis Biotherapeutics, Inc.ARQT | Healthcare | Sale | $1k–$15k | Sep 15, 2023 | $6.81 | $26.75 | Oct 15, 2023 | 30 days |
| Josh Gottheimer | Arcutis Biotherapeutics, Inc.ARQT | Healthcare | Purchase | $1k–$15k | Apr 17, 2023 | $13.98 | $26.75 | May 19, 2023 | 32 days |
Download ARQT congressional trades (CSV)Every politician who disclosed a trade in this symbol in the current snapshot.
RSS for ARQTNew congressional filings in this symbol, by filing date.
Educated guesstimate only. Filings report ranges, not exact sizes. Share counts use the range midpoint (or 1.5× the floor for “Over $X”) and the closing price on the trade date. Open lots are marked to the latest Yahoo Finance close. Cash dividends and split factors are applied while a reconstructed lot is open. Sales with no matching disclosed buy are treated as closing an unseen lot at the sale price (about $0 P/L on that slice). Bonds and rows without a usable ticker are excluded. This is not actual profit.